Analysts expect Sagimet Biosciences Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.55 M | 440,270.62 | 995,795.98 | 1.21 M | 5.81 M | 5.83 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.31 M | 382,505.18 | 844,809.28 | 1.02 M | 5.31 M | 5.42 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.43 M | 411,387.90 | 920,302.63 | 1.11 M | 5.56 M | 5.63 M |
Analysts expect Sagimet Biosciences Inc. to report earnings per share of -0.27 for Q3 26, against a range of -0.29 to -0.25. The most recent reported quarter, Q2 26, came in at -0.26, a 8.3% miss against the -0.24 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.45 | -0.50 | -0.56 | -0.32 | -0.40 | -0.29 | -0.33 | -0.26 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.35 | -0.59 | -0.61 | -0.46 | -0.36 | -0.39 | -0.32 | -0.23 | -0.25 | -0.27 | -0.28 | -0.30 | -0.28 | -0.28 | -0.39 | -0.34 | ||||||||||
| Low Estimate | -0.39 | -0.69 | -0.65 | -0.50 | -0.44 | -0.43 | -0.38 | -0.25 | -0.29 | -0.31 | -0.32 | -0.34 | -0.32 | -0.30 | -0.43 | -0.40 | ||||||||||
| Consensus Estimate | -0.37 | -0.64 | -0.63 | -0.48 | -0.40 | -0.41 | -0.35 | -0.24 | -0.27 | -0.29 | -0.30 | -0.32 | -0.30 | -0.29 | -0.41 | -0.37 |
Pull Wall Street consensus for Sagimet Biosciences Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SGMT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SGMT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SGMT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();